HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
about
The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus PeptidesSelection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaIncreased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.Progression to AIDS in SIV-Infected Rhesus Macaques is Associated with Distinct KIR and MHC class I Polymorphisms and NK Cell Dysfunction.Progress toward curing HIV infections with hematopoietic stem cell transplantation.Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsA Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children.Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replicationNatural Killer Cell Diversity in Viral Infection: Why and How Much?HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.Innate immunity against HIV-1 infection.HLA-B polymorphisms and intracellular assembly modes.Redefining Memory: Building the Case for Adaptive NK cells.α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.Profile of killer cell immunoglobulin-like receptor and its human leucocyte antigen ligands in dengue-infected patients from Western India.The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.Origins of Natural Killer Cell Memory: Special Creation or Adaptive Evolution.Vaccinating for natural killer cell effector functions.CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantationKIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in Homozygous Individuals
P2860
Q26753146-8A3DA3EB-B551-480D-8442-652C92B1D755Q27317377-5B6693F6-C722-4E98-95C4-9B683C62FD80Q28607344-FEC0E0D9-5366-4ADA-A6FD-EEEA0A8DC51BQ34339253-5B9EFC9A-3B4A-4BDB-8752-9A95EC450AC1Q34362162-6C115B48-BC51-4DA6-B403-6CB8B138BEEDQ34583325-62FE7163-D8AD-4BE8-8C1D-5F3F907B4916Q34974480-FC57D59B-5E89-4649-854B-4F86A92A46D2Q34992670-C3EC27A1-92E3-4431-9FA2-2D360D745F89Q35909272-592EF2A1-BFAC-423A-B8D5-BF384F8F2308Q36287590-FEF535D5-F5D8-4DC2-AEBB-4F632D185446Q36993967-1DEF6B8E-5A51-49F8-8502-C845E5BA1281Q37252674-A4B0238A-A76F-4F7A-8911-9519669D1BEDQ37532336-42D8FC4E-3F13-4954-B3E0-CDCD35A121AAQ38453875-45A64B4C-8795-4D50-9649-4182F9189D81Q38491184-183C8057-55AC-4BEB-9610-86E18288F3D2Q38560231-C5771550-50BC-4948-BC90-F2CE73B4F350Q38631761-18D908EF-017F-4D8C-ADD3-81D5116471FBQ38636110-2E64AA1A-7782-4989-B82B-CE6E6786A0A7Q40047218-F5DC1056-5C5A-4E22-A756-EC1B4AE4172BQ40052007-0F3202F7-DE1E-4C9E-AB28-0F8E5974F531Q40138609-DB1F54F9-0091-4804-B0E8-DBD762E1D01DQ40582355-FE6CBB1D-2E23-4930-A895-12A86202E9DAQ40760920-291163D5-60C2-43CC-8D05-E88E75BFF9FCQ41094835-379893B1-B5E5-4344-97B0-9747C035C9FEQ41914803-8EE9EF78-BD83-4467-8A62-13409763B114Q41918302-8011CD1E-02D2-47C1-8095-33AEE9047348Q46722989-18B92E2F-7F5A-4733-8DC6-AF04AE7DECB8Q47550532-2C1618D7-E4B7-4B24-A6C8-50FB1DAF1AABQ50301007-9537BFC4-7126-4789-8056-00AA7FCD3EADQ50849382-B715F903-FE28-484E-8F0C-6B0588E95355Q57053217-545B449B-6544-42EA-9F1C-75A7C739FFBEQ58789985-79757F8E-56D8-40A7-AC01-3AC56BFAB175
P2860
HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@en
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@nl
type
label
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@en
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@nl
prefLabel
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@en
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@nl
P2093
P2860
P1433
P1476
HIV protective KIR3DL1/S1-HLA- ...... ion in autologous CD4 targets.
@en
P2093
Bertrand Lebouché
Irene Lisovsky
Jean-Pierre Routy
Julie Bruneau
Nicole F Bernard
Rujun Song
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003867
P577
2014-01-16T00:00:00Z